chlorine has been researched along with Arterial Occlusive Diseases in 16 studies
chloride : A halide anion formed when chlorine picks up an electron to form an an anion.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Human obesity is associated with an increased risk for arterial and venous thrombosis and with elevated levels of leptin in the blood." | 7.72 | Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. ( Dellas, C; Konstantinides, S; Loskutoff, DJ; Neels, JG; Schäfer, K, 2004) |
| "Further to characterize the processes involved in the FeCl3-induced thrombosis model, we determined the effect of aspirin, heparin, hirudin, trans-4-(aminomethyl) cyclohexane carboxylic acid (AMCHA), thrombocytopenia, and flow modifications on time to occlusion (TTO) and thrombus weight (TW) in the rat carotid artery." | 7.70 | Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. ( Kambayashi, J; Lockyer, S, 1999) |
| "Ferric chloride has been widely used to induce arterial thrombosis in a variety of species." | 5.33 | An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. ( Wang, X; Xu, L, 2005) |
| "To determine how CD73 activity influences in vivo thrombosis, the time to ferric chloride-induced arterial thrombosis was measured in CD73-null mice." | 3.83 | Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice. ( Chepurko, E; Covarrubias, R; Cowan, PJ; Dwyer, KM; Gumina, RJ; Huttinger, R; Huttinger, ZM; Novitskaya, T; Reynolds, A; Robson, SC; Stanfill, K; Wheeler, DG, 2016) |
| " We hypothesized that anti-HSP60 autoantibodies could potentiate thrombosis, and evaluated the effect of anti-murine HSP60 antibodies in a ferric chloride (FeCl3)-induced murine model of carotid artery injury." | 3.75 | Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis. ( Dieudé, M; Gillis, MA; Lajoie, G; Levine, JS; Merhi, Y; Rauch, J; Théorêt, JF; Thorin, E, 2009) |
| "We used a model of carotid artery thrombosis induced by a ferric chloride injury to compare the time to first occlusion and occlusion rate at 25 min postinjury in mice lacking the collagen receptor, glycoprotein (GP) VI, or the ligand-binding domain of the VWF receptor, GP Ibalpha." | 3.73 | Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. ( Almus-Jacobs, F; Konstantinides, S; Loskutoff, DJ; Marchese, P; Ruggeri, ZM; Ware, J, 2006) |
| "Human obesity is associated with an increased risk for arterial and venous thrombosis and with elevated levels of leptin in the blood." | 3.72 | Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. ( Dellas, C; Konstantinides, S; Loskutoff, DJ; Neels, JG; Schäfer, K, 2004) |
| " In three different types of thrombosis models in rats, including stasis and thrombin-induced venous, glass surface-activated arterio-venous shunt, and ferric chloride-induced arterial thrombosis models, CX-397 and rHV-1 elicited potent antithrombotic effects, where the minimum effective doses of rHV-1 tended to be higher than those of CX-397 in the arterio-venous shunt and arterial thrombosis models." | 3.70 | Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban. ( Fukazawa, T; Goto, Y; Hayashi, H; Inoue, Y; Komatsu, Y, 1999) |
| "Further to characterize the processes involved in the FeCl3-induced thrombosis model, we determined the effect of aspirin, heparin, hirudin, trans-4-(aminomethyl) cyclohexane carboxylic acid (AMCHA), thrombocytopenia, and flow modifications on time to occlusion (TTO) and thrombus weight (TW) in the rat carotid artery." | 3.70 | Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. ( Kambayashi, J; Lockyer, S, 1999) |
| " In the dose-response study, a single administration of prasugrel at 0." | 1.42 | Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice. ( Jakubowski, JA; Mizuno, M; Ohno, K; Sugidachi, A; Tomizawa, A, 2015) |
| "This study compared arterial to venous thrombosis in the mutationally analogous Factor V Leiden mouse." | 1.34 | Increased venous versus arterial thrombosis in the Factor V Leiden mouse. ( Chen, CY; Cooley, BC; Schmeling, G, 2007) |
| "However, neither its role in thrombus formation and cardiovascular disorders nor its suitability as a therapeutic target structure is entirely clear." | 1.34 | Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions. ( Boehncke, WH; Krahn, T; Ludwig, RJ; Nieswandt, B; Oostingh, GJ; Pozgajova, M; Schön, MP, 2007) |
| "Ferric chloride has been widely used to induce arterial thrombosis in a variety of species." | 1.33 | An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. ( Wang, X; Xu, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, DH | 1 |
| Hsu, CC | 1 |
| Huang, SW | 1 |
| Tu, HJ | 1 |
| Huang, TF | 1 |
| Liou, HC | 1 |
| Liao, HM | 1 |
| Chen, CH | 1 |
| Fu, WM | 1 |
| Gau, SS | 1 |
| Assumpção, TC | 1 |
| Mizurini, DM | 1 |
| Ma, D | 1 |
| Monteiro, RQ | 1 |
| Ahlstedt, S | 1 |
| Reyes, M | 1 |
| Kotsyfakis, M | 1 |
| Mather, TN | 1 |
| Andersen, JF | 1 |
| Lukszo, J | 1 |
| Ribeiro, JMC | 1 |
| Francischetti, IMB | 1 |
| Ohno, K | 1 |
| Tomizawa, A | 1 |
| Jakubowski, JA | 1 |
| Mizuno, M | 1 |
| Sugidachi, A | 1 |
| Covarrubias, R | 1 |
| Chepurko, E | 1 |
| Reynolds, A | 1 |
| Huttinger, ZM | 1 |
| Huttinger, R | 1 |
| Stanfill, K | 1 |
| Wheeler, DG | 1 |
| Novitskaya, T | 1 |
| Robson, SC | 1 |
| Dwyer, KM | 1 |
| Cowan, PJ | 1 |
| Gumina, RJ | 1 |
| Dieudé, M | 1 |
| Gillis, MA | 1 |
| Théorêt, JF | 1 |
| Thorin, E | 1 |
| Lajoie, G | 1 |
| Levine, JS | 1 |
| Merhi, Y | 1 |
| Rauch, J | 1 |
| Baumgartner, B | 1 |
| Jaki, T | 1 |
| Wolfsegger, MJ | 1 |
| Eder, B | 1 |
| Schiviz, A | 1 |
| Schwarz, HP | 1 |
| Muchitsch, EM | 1 |
| Korporaal, SJ | 1 |
| Meurs, I | 1 |
| Hauer, AD | 1 |
| Hildebrand, RB | 1 |
| Hoekstra, M | 1 |
| Cate, HT | 1 |
| Praticò, D | 1 |
| Akkerman, JW | 1 |
| Van Berkel, TJ | 1 |
| Kuiper, J | 1 |
| Van Eck, M | 1 |
| Konstantinides, S | 2 |
| Schäfer, K | 1 |
| Neels, JG | 1 |
| Dellas, C | 1 |
| Loskutoff, DJ | 2 |
| Wang, X | 1 |
| Xu, L | 1 |
| Matuskova, J | 1 |
| Chauhan, AK | 1 |
| Cambien, B | 1 |
| Astrof, S | 1 |
| Dole, VS | 1 |
| Piffath, CL | 1 |
| Hynes, RO | 1 |
| Wagner, DD | 1 |
| Cooley, BC | 1 |
| Chen, CY | 1 |
| Schmeling, G | 1 |
| Ware, J | 1 |
| Marchese, P | 1 |
| Almus-Jacobs, F | 1 |
| Ruggeri, ZM | 1 |
| Oostingh, GJ | 1 |
| Pozgajova, M | 1 |
| Ludwig, RJ | 1 |
| Krahn, T | 1 |
| Boehncke, WH | 1 |
| Nieswandt, B | 1 |
| Schön, MP | 1 |
| Nielsen, HT | 1 |
| Olcott, EW | 1 |
| Nishimura, DG | 1 |
| Komatsu, Y | 1 |
| Inoue, Y | 1 |
| Goto, Y | 1 |
| Fukazawa, T | 1 |
| Hayashi, H | 1 |
| Lockyer, S | 1 |
| Kambayashi, J | 1 |
16 other studies available for chlorine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
ARHGEF10 knockout inhibits platelet aggregation and protects mice from thrombus formation.
Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Carotid Artery Diseases; Cell Shape; Chloride | 2017 |
Ixonnexin from Tick Saliva Promotes Fibrinolysis by Interacting with Plasminogen and Tissue-Type Plasminogen Activator, and Prevents Arterial Thrombosis.
Topics: Animals; Arterial Occlusive Diseases; Chlorides; Ferric Compounds; Fibrinolysis; Mice; Noxae; Plasmi | 2018 |
Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice.
Topics: Adenosine Diphosphate; Animals; Aorta; Arterial Occlusive Diseases; Arteries; Carotid Arteries; Chem | 2015 |
Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; | 2016 |
Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis.
Topics: Animals; Arterial Occlusive Diseases; Autoantibodies; Carotid Artery Diseases; Chaperonin 60; Chlori | 2009 |
Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia A.
Topics: Animal Use Alternatives; Animal Welfare; Animals; Arterial Occlusive Diseases; Carotid Artery Diseas | 2010 |
Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol.
Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Bone Marrow Transplantation; Chlorides; Chole | 2011 |
Inhibition of endogenous leptin protects mice from arterial and venous thrombosis.
Topics: Animals; Antibodies, Blocking; Arterial Occlusive Diseases; Chlorides; Ferric Compounds; Leptin; Mic | 2004 |
An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research.
Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Chlorides; Clopidogrel; Disease Model | 2005 |
Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles.
Topics: Alternative Splicing; Animals; Arterial Occlusive Diseases; Arterioles; Bleeding Time; Blood Coagula | 2006 |
Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
Topics: Amino Acid Substitution; Animals; Arginine; Arterial Occlusive Diseases; Arteries; Chlorides; Diseas | 2007 |
Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis.
Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Thrombosis; Chlorides; Disease Models, Animal; | 2006 |
Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
Topics: Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Chlorides; Drug Evaluation, Preclinica | 2007 |
Improved 2D time-of-flight angiography using a radial-line k-space acquisition.
Topics: Arterial Occlusive Diseases; Artifacts; Blood Vessels; Chlorides; Humans; Image Enhancement; Image P | 1997 |
Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
Topics: Amino Acid Sequence; Animals; Arginine; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; | 1999 |
Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis.
Topics: Animals; Antifibrinolytic Agents; Antithrombins; Arterial Occlusive Diseases; Aspirin; Blood Platele | 1999 |